EPISODE · Jun 8, 2026 · 1 MIN
Inside the Phase 3 BREAKWATER Trial: First-Line BRAF V600E-Mutant Metastatic Colorectal Cancer
from TheBrief.Health · host TheBrief.Health
ASCO 2026 data highlight rising early-onset cancers, prompting earlier screening, genomic testing, fertility-focused care, and heightened suspicion as diagnoses increasingly affect younger adults worldwide today.
What this episode covers
ASCO 2026 data highlight rising early-onset cancers, prompting earlier screening, genomic testing, fertility-focused care, and heightened suspicion as diagnoses increasingly affect younger adults worldwide today.
NOW PLAYING
Inside the Phase 3 BREAKWATER Trial: First-Line BRAF V600E-Mutant Metastatic Colorectal Cancer
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m